Drug Trial Radar · NCT05897541
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
Last checked: Nov 20, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,701
Actual
Start
Jun 9, 2023
Primary completion
Aug 30, 2024
Study completion Sep 18, 2024
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Jun 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (positive reverse transcription polymerase chain reaction \[RT-PCR\] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo tablets in participants who are household contacts of an individual with symptomatic COVID-19.
Conditions
- SARS-CoV-2 Infection
Interventions
S-217622Drug
Administered as a tablet.
PlaceboDrug
Administered as a tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants in mITT Population Who Were Infected With SARS-CoV-2 and Had Coronavirus Disease 2019 (COVID-19) Symptoms OnsetTime frame: Day 1 up to Day 10
Locations
178 sites in 5 countries. Site status is shown where the registry gives one.
Central Alabama Research
Birmingham, Alabama
Accel Research Site - Achieve - Birmingham - ERN - PPDS
Birmingham, Alabama
Cullman Clinical Trials
Cullman, Alabama
Absolute Clinical Research, LLC
Phoenix, Arizona
One of a Kind Clinical Research Center LLC
Scottsdale, Arizona
Healthstar Research
Hot Springs, Arkansas
Preferred Research Partners - ClinEdge - PPDS
Little Rock, Arkansas
Neighborhood Healthcare
Escondido, California
Apex Research Group
Fair Oaks, California
Ascada Research LLC
Fullerton, California
Torrance Clinical Research Institute
Lomita, California
Ark Clinical Research - Long Beach - ClinEdge - PPDS
Long Beach, California
Rancho Cucamonga Clinical Research
Rancho Cucamonga, California
Smart Cures Clinical Research
Rolling Hills Estates, California
Clinical Trials Management Services, LLC
Thousand Oaks, California
Lynn Institute of The Rockies - ERN - PPDS
Colorado Springs, Colorado
TrueBlue Clinical Research
Brandon, Florida
Invictus Clinical Research Group, LLC
Coconut Creek, Florida
Universal Medical and Research Center, LLC
Coral Gables, Florida
Hope Clinical Trials
Coral Gables, Florida
I.V.A.M. Clinical & Investigational Center
Doral, Florida
Quality Research of South Florida
Hialeah, Florida
Universal Medical and Research Center, LLC Homestead
Homestead, Florida
Flourish Research - Leesburg - PPDS
Leesburg, Florida
Premier Clinical Research Institute - Miami - ClinEdge - PPDS
Miami, Florida
LCC Medical Research - Miami - ClinEdge - PPDS
Miami, Florida
CCM Clinical Research Group
Miami, Florida
Suncoast Research Group LLC - Flourish - PPDS
Miami, Florida
University of Miami - 1150 NW 14th St
Miami, Florida
Florida Research Center, Inc.
Miami, Florida
Oceane7 Medical & Research Center, Inc.
Miami, Florida
Continental Clinical Research, LLC
Miami, Florida
BioClinical Research Alliance
Miami, Florida
Ivetmar Medical Group, LLC
Miami, Florida
Miami Clinical Research - ClinEdge - PPDS
Miami, Florida
Global Health Clinical Trials
Miami, Florida
Valencia Medical and Research Center
Miami, Florida
Alma Research
Miami, Florida
GCP Global Clinical Professionals, LLC
Miami, Florida
Research Institute of South Florida Inc
Miami, Florida
Showing 40 of 178 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.